Published in Retina on June 01, 2011
Stem cells in retinal regeneration: past, present and future. Development (2013) 1.59
Stem cell therapy for retinal diseases: update. Stem Cell Res Ther (2011) 1.05
Developing cellular therapies for retinal degenerative diseases. Invest Ophthalmol Vis Sci (2014) 1.03
Stem cell treatment of degenerative eye disease. Stem Cell Res (2015) 0.99
Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest Ophthalmol Vis Sci (2012) 0.93
Novel drugs and their targets in the potential treatment of diabetic retinopathy. Med Sci Monit (2013) 0.90
Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest Ophthalmol Vis Sci (2014) 0.89
Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell -clinical trial). Stem Cell Res Ther (2015) 0.89
Stem cell therapies for age-related macular degeneration: the past, present, and future. Clin Interv Aging (2015) 0.87
Multimodal Imaging of Central Retinal Disease Progression in a 2-Year Mean Follow-up of Retinitis Pigmentosa. Am J Ophthalmol (2015) 0.87
Retinoid uptake, processing, and secretion in human iPS-RPE support the visual cycle. Invest Ophthalmol Vis Sci (2014) 0.86
Ophthalmologic stem cell transplantation therapies. Regen Med (2012) 0.86
Psychophysically determined full-field stimulus thresholds (FST) in retinitis pigmentosa: relationships with electroretinography and visual field outcomes. Doc Ophthalmol (2013) 0.85
Stem cell-based therapies for age-related macular degeneration: current status and prospects. Int J Clin Exp Med (2014) 0.85
Recent advances of stem cell therapy for retinitis pigmentosa. Int J Mol Sci (2014) 0.81
Advances in bone marrow stem cell therapy for retinal dysfunction. Prog Retin Eye Res (2016) 0.79
Assessment of "non-recordable" electroretinograms by 9 Hz flicker stimulation under scotopic conditions. Doc Ophthalmol (2011) 0.79
Effect of In Vitro Exposure of Corticosteroid Drugs, Conventionally Used in AMD Treatment, on Mesenchymal Stem Cells. Stem Cells Int (2012) 0.78
Transplantation of IL-10-transfected endothelial progenitor cells improves retinal vascular repair via suppressing inflammation in diabetic rats. Graefes Arch Clin Exp Ophthalmol (2016) 0.77
Stem cell therapies in the treatment of diabetic retinopathy and keratopathy. Exp Biol Med (Maywood) (2015) 0.76
Transdifferentiation of periodontal ligament-derived stem cells into retinal ganglion-like cells and its microRNA signature. Sci Rep (2015) 0.76
Translational research in retinology. Clin Ophthalmol (2011) 0.76
Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model. PLoS One (2016) 0.75
Stem cell therapy in retinal diseases? Rev Bras Hematol Hemoter (2012) 0.75
Intravitreal Injection of Bone Marrow Mesenchymal Stem Cells in Patients with Advanced Retinitis Pigmentosa; a Safety Study. J Ophthalmic Vis Res (2017) 0.75
Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber's hereditary optic neuropathy. Neural Regen Res (2016) 0.75
Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study. Stem Cell Res Ther (2016) 0.75
Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes. PLoS One (2016) 0.75
Effect of endothelial progenitor cells derived from human umbilical cord blood on oxygen-induced retinopathy in mice by intravitreal transplantation. Int J Ophthalmol (2016) 0.75
Biobanking of Human Retinas: The Next Big Leap for Eye Banks? Stem Cells Transl Med (2015) 0.75
Retinal Degeneration and Regeneration-Lessons From Fishes and Amphibians. Curr Pathobiol Rep (2017) 0.75
Intravitreal use of bone marrow mononuclear fraction containing CD34(+) stem cells in patients with atrophic age-related macular degeneration. Clin Ophthalmol (2017) 0.75
Major challenges in vitreoretinal surgery. Taiwan J Ophthalmol (2014) 0.75
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2003) 4.78
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology (2007) 3.49
Evolving guidelines for intravitreous injections. Retina (2004) 3.39
Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol (2004) 2.98
Acute zonal occult outer retinopathy: a long-term follow-up study. Am J Ophthalmol (2002) 2.92
Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol (2005) 2.66
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol (2009) 2.48
Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 2.20
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer (2003) 2.06
Clinical practice. Retinal-vein occlusion. N Engl J Med (2010) 2.05
Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology (2006) 1.91
Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol (2004) 1.91
Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy. Acta Ophthalmol Scand (2006) 1.90
Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina (2002) 1.86
Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology (2007) 1.79
Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials. Arch Ophthalmol (2005) 1.77
Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol (2006) 1.75
Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography. Br J Ophthalmol (2006) 1.74
Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol (2004) 1.74
Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial. Am J Ophthalmol (2008) 1.68
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology (2008) 1.60
Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina (2007) 1.59
Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study. Invest Ophthalmol Vis Sci (2006) 1.59
Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis (2004) 1.55
Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology (2008) 1.51
Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology (2004) 1.50
Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up. Acta Ophthalmol (2014) 1.49
Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol (2008) 1.47
SCORE Study report 3: study design and baseline characteristics. Ophthalmology (2009) 1.47
Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology (2008) 1.47
Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina (2006) 1.45
Disclosure of resident involvement in ophthalmic surgery. Arch Ophthalmol (2012) 1.40
Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology (2010) 1.40
Reducing the risk of endophthalmitis following intravitreal injections. Retina (2007) 1.39
Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging (2005) 1.38
Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology (2003) 1.36
Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci (2008) 1.36
Impact of resident participation in cataract surgery on operative time and cost. Ophthalmology (2011) 1.35
Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology (2002) 1.32
Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. Ophthalmology (2010) 1.32
Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes. Ophthalmology (2003) 1.29
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol (2004) 1.28
Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology. Ophthalmology (2012) 1.23
Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled exploratory study. Invest Ophthalmol Vis Sci (2011) 1.21
Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Invest Ophthalmol Vis Sci (2005) 1.21
Retinal detachment surgery with silicone oil injection in transconjunctival sutureless 23-gauge vitrectomy. Arq Bras Oftalmol (2008) 1.19
Optical coherence tomography findings in patients with late solar retinopathy. Am J Ophthalmol (2004) 1.18
Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology (2002) 1.18
Anti-VEGF Treatment Strategies for Wet AMD. J Ophthalmol (2012) 1.17
A survey of the role of virtual surgery simulators in ophthalmic graduate medical education. Graefes Arch Clin Exp Ophthalmol (2010) 1.16
Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand (2006) 1.15
Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol (2004) 1.12
Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study). Graefes Arch Clin Exp Ophthalmol (2007) 1.12
In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol (2006) 1.11
Endophthalmitis caused by Moraxella osloensis. Graefes Arch Clin Exp Ophthalmol (2002) 1.08
Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy. Br J Ophthalmol (2011) 1.06
SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion. Ophthalmology (2011) 1.06
The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4. Arch Ophthalmol (2009) 1.06
Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm. Prog Retin Eye Res (2005) 1.06
Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers (2002) 1.05
One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion. Retina (2006) 1.05
Vision loss associated with the use and removal of intraocular silicone oil. Clin Ophthalmol (2008) 1.02
Possible mechanisms of retinal function recovery with the use of cell therapy with bone marrow-derived stem cells. Arq Bras Oftalmol (2011) 1.01
A prospective randomized trial of intravitreal bevacizumab versus ranibizumab for the management of diabetic macular edema. Am J Ophthalmol (2013) 1.00
Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol (2007) 1.00
Retinal detachment in eyes undergoing pars plana vitrectomy for removal of retained lens fragments. Ophthalmology (2003) 1.00
Multimodal fundus imaging in Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol (2010) 0.99
Quantifying fixation in patients with Stargardt disease. Vision Res (2007) 0.98
A multicenter analysis of the ophthalmic knowledge assessment program and American Board of Ophthalmology written qualifying examination performance. Ophthalmology (2012) 0.98
Implantation of second glaucoma drainage devices after failure of primary devices. Ophthalmic Surg Lasers (2002) 0.97
Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes. Ophthalmic Surg Lasers Imaging (2007) 0.97
Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9. Arch Ophthalmol (2010) 0.96
Ocular findings in a patient with Castleman's disease before and after treatment with immunosuppression and plasmapheresis. Ophthalmic Surg Lasers Imaging (2010) 0.95
Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging (2003) 0.94
Endophthalmitis caused by Bacillus species. Am J Ophthalmol (2008) 0.93
Legacy of the endophthalmitis vitrectomy study. Arch Ophthalmol (2008) 0.93
Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling. J Cell Mol Med (2012) 0.93
Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab. Ophthalmic Surg Lasers Imaging (2009) 0.93
Mitomycin C versus 5-fluorouracil as an adjunctive treatment for trabeculectomy: a meta-analysis of randomized clinical trials. Clin Experiment Ophthalmol (2013) 0.93
Acute acquired toxoplasma retinitis may present similarly to unilateral acute idiopathic maculopathy. Am J Ophthalmol (2004) 0.92
Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma. J Glaucoma (2002) 0.92
Scleral buckle for progressive symptomatic retinal detachment complicating retinoschisis versus primary rhegmatogenous retinal detachment. Can J Ophthalmol (2010) 0.91
Endophthalmitis caused by Haemophilus influenzae. Ophthalmology (2004) 0.91
Potential impact of seatbelt use on the spectrum of ocular injuries and visual acuity outcomes after motor vehicle accidents with airbag deployment. Ophthalmology (2007) 0.90
Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. Acta Ophthalmol (2011) 0.90
Early onset endophthalmitis caused by Aspergillus species following cataract surgery. Am J Ophthalmol (2006) 0.90